Jijumon Chelliserry

Jijumon Chelliserry is currently the Director of Biomarker Assay in Oncology at Pfizer, where they execute Translational Oncology Biomarker strategies and oversee the management of partners in clinical trial biomarker sample analyses. With over 15 years of experience in the molecular diagnostics and pharmaceuticals industry, they have held roles including Senior Manager at Pfizer and Associate Director at GenomeDx Biosciences Inc. Jijumon's prior experience includes serving as a Senior Scientist at Hologic Inc., and a Post Doctoral Fellow at Stanford University. They hold an M.S. in Chemistry from the Indian Institute of Technology, Madras, and a Ph.D. in Chemistry and Biochemistry from The University of Texas at Austin.